G. Cohn-Cedermark

发表

2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial.

A. Horwich, J. Gampe, K. Oechsle, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial

A. Horwich, J. Gampe, K. Oechsle, 2011 .

Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer Group.

R. Wahlqvist, O. Ståhl, M. Jerkeman, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Emotional disorders in testicular cancer survivors in relation to hypogonadism, androgen receptor polymorphism and treatment modality.

A. Giwercman, O. Ståhl, L. Rylander, 2010, Journal of affective disorders.

Cancer therapy and risk of congenital malformations in children fathered by men treated for testicular germ-cell cancer: A nationwide register study

A. Giwercman, O. Ståhl, L. Rylander, 2019, PLoS medicine.

High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer – a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA)

R. Bremnes, H. Haugnes, O. Dahl, 2012, Acta oncologica.

Prognostic factors in cystosarcoma phyllodes. A clinicopathologic study of 77 patients

L. Rutqvist, C. Silfverswärd, I. Rosendahl, 1991, Cancer.

EAU Guidelines on testicular cancer, 2011 update

A. Horwich, P. Albers, C. Bokemeyer, 2012 .

Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma.

C. Bokemeyer, J. Shamash, C. Fankhauser, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Androgen receptor gene CAG and GGN repeat lengths as predictors of recovery of spermatogenesis following testicular germ cell cancer treatment

S. Arver, A. Giwercman, O. Ståhl, 2016, Asian journal of andrology.

The SWENOTECA group: A good example of continuous binational and multidisciplinary collaboration for patients with testicular cancer in Sweden and Norway

R. Wahlqvist, O. Ståhl, O. Klepp, 2016, Scandinavian journal of urology.

Guidelines EAU Guidelines on Testicular Cancer : 2011 Update

A. Horwich, P. Albers, C. Bokemeyer, 2012 .

European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II.

S. Fosså, S. Culine, A. Horwich, 2008, European urology.

Guidelines on Testicular Cancer: 2015 Update.

A. Horwich, P. Albers, C. Bokemeyer, 2015, European urology.

2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial.

A. Horwich, J. Gampe, K. Oechsle, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Initial surveillance in men with marker negative clinical stage IIA non‐seminomatous germ cell tumours

R. Wahlqvist, A. Thor, O. Ståhl, 2024, BJU international.

Sexual function in men treated for testicular cancer.

A. Giwercman, O. Ståhl, L. Rylander, 2009, The journal of sexual medicine.

European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I.

S. Fosså, S. Culine, A. Horwich, 2008, European urology.

Guidelines on testicular cancer.

A. Horwich, P. Albers, C. Bokemeyer, 2005, European urology.

Guidelines on Testicular Cancer: 2015 Update.

A. Horwich, P. Albers, C. Bokemeyer, 2015, European urology.

Diagnosis, staging, and risk factors: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009.

P. Albers, J. Moul, F. Algaba, 2011, Urology.

Sperm count in Swedish clinical stage I testicular cancer patients following adjuvant treatment.

S. Arver, A. Giwercman, O. Ståhl, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

A genome-wide association study of men with symptoms of testicular dysgenesis syndrome and its network biology interpretation

S. Brunak, J. Toppari, H. Leffers, 2011, Journal of Medical Genetics.

Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance.

T. Powles, P. Warde, S. Tyldesley, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long term results of a randomized study by the Swedish Melanoma Study Group on 2‐cm versus 5‐cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8–2.0 mm

C. Ingvar, U. Ringborg, P. Jönsson, 2000, Cancer.

Outcomes of patients with local recurrence of cutaneous malignant melanoma

U. Ringborg, L. Rutqvist, G. Cohn-Cedermark, 1997, Cancer.

Early salvage radiation therapy combined with short-term hormonal therapy in recurrent prostate cancer after radical prostatectomy: single-institution 4-year data on outcome, toxicity, health-related quality of life and co-morbidities from 184 consecutive patients treated with 70 Gy.

P. Wiklund, U. Harmenberg, S. Nilsson, 2013, International journal of oncology.

ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up

D. Berney, S. Fosså, A. Horwich, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

S. Fosså, A. Horwich, R. Huddart, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Central nervous system metastases of cutaneous malignant melanoma--a population-based study.

U. Ringborg, H. Johansson, L. Rutqvist, 1998, Acta oncologica.

Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group.

R. Wahlqvist, O. Ståhl, H. Haugnes, 2020, European urology oncology.

EAU guidelines on testicular cancer: 2011 update.

A. Horwich, P. Albers, C. Bokemeyer, 2011, European urology.

Trends in mortality from malignant melanoma in Sweden, 1970–1996

U. Ringborg, H. Johansson, L. Rutqvist, 2000, Cancer.

Clinical outcome in patients with prostate cancer treated with external beam radiotherapy and high dose-rate iridium 192 brachytherapy boost: A 6-year follow-up

J. Fowler, S. Nilsson, M. Hellström, 2007, Acta oncologica.

Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma.

J. Shamash, P. Hutton, O. Ståhl, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study.

R. Bremnes, O. Dahl, E. Cavallin-ståhl, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program.

R. Bremnes, O. Klepp, O. Dahl, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Inhibin B concentration is predictive for long‐term azoospermia in men treated for testicular cancer

S. Arver, A. Giwercman, O. Ståhl, 2014, Andrology.

Association of polymorphisms in genes encoding hormone receptors ESR1, ESR2 and LHCGR with the risk and clinical features of testicular germ cell cancer

S. Arver, A. Giwercman, O. Ståhl, 2012, Molecular and Cellular Endocrinology.

One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group.

O. Ståhl, H. Haugnes, O. Dahl, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.